Tactile suppression from N-Ethylhexedrone

Tactile suppression is the experience of a diminished ability to perceive physical touch, resulting in a general numbness that can range from mild reduction in sensitivity to complete anaesthesia of the entire body. The effect creates a sense of disconnection from physical sensations, as though a barrier has been placed between one's awareness and the surface of the skin.

At lower intensities, tactile suppression manifests as a mild dulling of sensation where physical contact feels muted or distant. Textures lose their detail, temperature perception becomes blunted, and the skin may feel as though it is covered by a thin, invisible layer that dampens incoming signals. The body may feel slightly heavy or numb in localized areas, particularly in the extremities such as the hands and feet.

As the effect intensifies, the numbness spreads and deepens. Large regions of the body may lose almost all tactile sensation, making it difficult to gauge pressure, temperature, or the position of one's own limbs without looking. At higher levels, the entire body can become fully anaesthetized, with physical sensations completely blocked. This can produce a profound sense of disembodiment, as though one's consciousness has become detached from the physical form entirely.

Tactile suppression is closely associated with pain relief, as the same mechanism that reduces general touch sensitivity also diminishes the perception of pain signals. This analgesic quality can be therapeutically useful but also presents a significant safety concern, as individuals may be unaware of injuries sustained while in this state. The inability to feel pain or physical damage means that one could unknowingly harm themselves through excessive physical activity or exposure to extreme temperatures.

This effect is most commonly induced under the influence of moderate to heavy dosages of dissociative compounds such as ketamine, PCP, and DXM, where it is a core feature of the dissociative experience. It also occurs with opioid analgesics, certain GABAergic depressants like alcohol and benzodiazepines, and some anaesthetic agents. The effect is often accompanied by physical euphoria, motor control loss, and disconnective states.